Statistics for Hidroclorotiazida y espironolactona reducen la hipertrofia de la pared aórtica en la hipertensión arterial experimental
Total visits
| views | |
|---|---|
| Hidroclorotiazida y espironolactona reducen la hipertrofia de la pared aórtica en la hipertensión arterial experimental | 200 |
Total visits per month
| views | |
|---|---|
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 2 |
| July 2024 | 1 |
| August 2024 | 0 |
File Visits
| views | |
|---|---|
| Hidroclorotiazida y espironolactona reducen la hipertrofia de la pared aórtica en la hipertensión arterial experimental.pdf | 30 |
Top country views
| views | |
|---|---|
| United States | 44 |
| Chile | 34 |
| Germany | 7 |
| China | 1 |
| Finland | 1 |
| Iran | 1 |
| Mexico | 1 |
| Singapore | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 29 |
| Concepcion | 5 |
| Alameda | 4 |
| Balingen | 1 |
| Campbell | 1 |
| Changi | 1 |
| Hanoi | 1 |
| Jacksonville | 1 |
| Kempen | 1 |
| Sacramento | 1 |
| Zapopan | 1 |